title: [Pharmacogenetics of community-acquired pneumonia].
abstract: The rate of acetylation of xenobiotics affects the course and prognosis of infectious diseases. The efficacy of antibiotic therapy of community-acquired pneumonia in RA-patients is lower than that in LA-ones. In order to ensure the best antimicrobial effect on the onset of the disease it is required to use regimens with the maximum permissible dose of antibacterial drugs in the regions where the rapid type prevails.
authors.forename: S Sh
authors.initials: SSh
authors.lastname: Suleĭmanov
authors.forename: O V
authors.initials: OV
authors.lastname: Molchanova
authors.forename: N V
authors.initials: NV
authors.lastname: Kirpichnikova
authors.forename: N V
authors.initials: NV
authors.lastname: Sukhotina
authors.forename: A A
authors.initials: AA
authors.lastname: Gorbach
mesh_terms: D000107:Acetylation; D000328:Adult; D000900:Anti-Bacterial Agents / Q000493:pharmacokinetics* / Q000627:therapeutic use; D017714:Community-Acquired Infections / Q000188:drug therapy* / Q000378:metabolism*; D006801:Humans; D007538:Isoniazid / Q000493:pharmacokinetics* / Q000627:therapeutic use; D018410:Pneumonia, Bacterial / Q000188:drug therapy* / Q000378:metabolism*
chemical_list: D000900:Anti-Bacterial Agents; D007538:Isoniazid